ClinicalTrials.Veeva

Menu

Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

HIV Positive Youth That Are Newly Engaged in Care

Treatments

Behavioral: HEALTH
Behavioral: Project ACCEPT

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01751620
ATN 108

Details and patient eligibility

About

The proposed study is a two-group randomized repeated measures design that will examine the efficacy of Project ACCEPT (Adolescents Coping, Connecting, Empowering and Protecting Together) to improve engagement in care among youth newly diagnosed with HIV at five AMTU sites across the United States. Youth will be randomized into one of two study arms; Project ACCEPT, the intervention, or HEALTH, the health education attention-controlled comparison condition. Both arms consist of two individual sessions followed by six group sessions and a final individual session which is expected to take approximately nine weeks after which youth will have four follow-up visits at the following time points:

  • post intervention (immediately after the last session);
  • 3 months post the last session;
  • 6 months post the last session; and
  • 12 months post the last session. The trial will be repeated in up to three waves.

Enrollment

167 patients

Sex

All

Ages

16 to 24 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV-infected and aware of his/her status as documented by medical record review or verbal verification by provider (i.e., medical or mental health care provider, case manager, social worker, etc.);
  • Received HIV diagnosis within the past 12 months (+ 3 months) at the time of consent/assent as documented by medical record review or verbal verification with referring professional (i.e., medical or mental health care provider, case manager, social worker, etc.);
  • Between the ages of 16-24 (inclusive) at the time of informed consent/assent;
  • Receives services at one of the selected AMTUs or one of their community partners;
  • Willing to participate in both the individual and group sessions;
  • Ability to speak and understand spoken English;
  • Able to understand and willing to provide signed informed consent/assent in English or Spanish; and
  • Willingness to provide signed informed consent or assent with parental/legal guardian permission as applicable.

Exclusion criteria

  • Participated in a previous wave, if enrolling into Wave 2 or 3;
  • Intoxicated or under the influence of alcohol or other substances at the time of consent/assent;
  • Visibly distraught and/or visibly emotionally unstable (i.e., exhibiting suicidal, homicidal, or violent behavior) in the opinion of the site personnel would interfere with the ability to give true informed consent; and
  • Any concurrent participation in other behavioral studies. Permission from the protocol team may be provided for uncertain cases.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

167 participants in 2 patient groups

Project ACCEPT
Experimental group
Description:
Participants randomized to the intervention (Project ACCEPT) arm.
Treatment:
Behavioral: Project ACCEPT
HEALTH
Active Comparator group
Description:
Participants randomized to the comparison (HEALTH) arm.
Treatment:
Behavioral: HEALTH

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems